Chemia Biosciences

Chemia Biosciences is a biotechnology company specializing in AI-enabled drug discovery from natural products. Spun out of Carnegie Mellon University's School of Computer Science, the company utilizes proprietary computational platforms, including NRPMiner, Seq2Saccharide, and Seq2PKS, to integrate genome mining with metabolomics. This approach allows for the rapid identification of novel bioactive small molecules, such as nonribosomal peptides and polyketides, which are often undetectable by traditional methods. Chemia Biosciences focuses on developing leads for drug-resistant infections, orphan diseases, and agricultural applications. The company partners with pharmaceutical firms and academic institutions to accelerate the discovery of next-generation therapeutics and crop protection solutions.